Atara Biotherapeutics ATRA
NASDAQ ATRA
$8.23 +0.13 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Atara Biotherapeutics (ATRA) Gains (Losses) on Sale of Assets & Investments (2014 - 2026)

Updated

Atara Biotherapeutics' Non Operating Investment Income came in at $50.24 million for FY2022.

Analysis

Atara Biotherapeutics (ATRA) Gains (Losses) on Sale of Assets & Investments (2014 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Atara Biotherapeutics 124.14 Mn 114.24 Mn 959,000.00 1,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 1,000.00
Jun 30, 2026 -2,000.00
Mar 31, 2026 -1,000.00
Dec 31, 2025 -1,000.00
Sep 30, 2025 2,000.00
Mar 31, 2025 -8,000.00
Dec 31, 2024 -14,000.00
Sep 30, 2024 36,000.00
Jun 30, 2024 41,000.00
Mar 31, 2024 149,000.00
Mar 31, 2023 830,000.00
Jun 30, 2022 50.24 Mn
Mar 31, 2022 -1.52 Mn
Mar 31, 2021 -135,000.00
Dec 31, 2020 -13,000.00
Sep 30, 2020 -283,000.00
Jun 30, 2020 606,000.00
Mar 31, 2020 -16,000.00
Dec 31, 2019 109,000.00
Sep 30, 2019 60,000.00
API Access

Atara Biotherapeutics Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=ATRA&period=max&api_key=YOUR_API_KEY